Nikibakhsh Ahmad-Ali, Mahmoodzadeh Hashem, Vali Mohamad, Enashaei Ali, Asem Abdolreza, Yekta Zahra
Nephrology-Urology and Transplantation Research Center, Urmia University of Medical Sciences, Iran.
Iran J Pediatr. 2013 Apr;23(2):171-6.
Peritoneal dialysis remains the only available option for patients which need immediate dialysis and it could be a bridge between end-stage renal failure (ESRD) and transplantation. There is a paucity of published experience of children with immediate use of permanent Tenckhoff Catheter for peritoneal dialysis from developing countries. In this study we report our experience on immediate use of permanent peritoneal access and continued peritoneal dialysis for a prolonged time.
Fifty six patients were studied including 30 males and 26 females within the age range of 1 month to 14 years with mean age of 6.5 years in Urmia, Northwest Iran.
No operative morbidity was seen. During a total of 499.5 continuous ambulatory peritoneal dialysis months, 16 patients had 28 episodes of peritonitis, which means a overall result of one episode per 17.8 months. There were 3 patients (5.35%) with catheter site leakage, 12 (21.4%) catheter obstructions (which led to omentectomy), 4 (7.2%) exit site infections (2 patients in the early postoperative period and 2 patients in during follow up). Death due to catheter related complications occurred in 1 per 56 patients and due to non-catheter related causes in 10 per 56 patients.
Present results indicate that catheter-related complications were not higher than those previously reported and peritoneal dialysis could be initiated immediately after catheter implantation and could be a safe bridge between end-stage renal failure (ESRD) and transplantation.
腹膜透析仍是需要立即进行透析的患者唯一可用的选择，它可以作为终末期肾衰竭（ESRD）与移植之间的桥梁。发展中国家关于儿童立即使用永久性Tenckhoff导管进行腹膜透析的已发表经验很少。在本研究中，我们报告了我们在立即使用永久性腹膜通路并长期持续进行腹膜透析方面的经验。
研究了56例患者，包括30例男性和26例女性，年龄在1个月至14岁之间，位于伊朗西北部的乌尔米亚，平均年龄为6.5岁。
未观察到手术相关并发症。在总共499.5个持续非卧床腹膜透析月期间，16例患者发生了28次腹膜炎发作，这意味着总体结果是每17.8个月发作一次。有3例患者（5.35%）出现导管部位渗漏，12例（21.4%）出现导管阻塞（导致网膜切除术），4例（7.2%）出现出口部位感染（2例在术后早期，2例在随访期间）。每56例患者中有1例因导管相关并发症死亡，每56例患者中有10例因非导管相关原因死亡。
目前的结果表明，导管相关并发症并不高于先前报道的情况，并且在导管植入后可立即开始腹膜透析，它可以作为终末期肾衰竭（ESRD）与移植之间的安全桥梁。
